Viewing Study NCT05122767


Ignite Creation Date: 2025-12-25 @ 12:31 AM
Ignite Modification Date: 2026-05-27 @ 2:08 AM
Study NCT ID: NCT05122767
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-12
First Post: 2021-08-09
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Rifapentine and Isoniazid TB Preventive Therapy (3HP) for Children Taking Dolutegravir-based Antiretroviral Treatment (DOLPHIN KIDS)
Sponsor: The Aurum Institute NPC
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Tuberculosis View
None HIV View
Keywords:

Keywords

Keyword Brief Keyword Text View
None TB View
None 3HP View
None pharmacokinetic View
None rifapentine View
None isoniazid View
None dolutegravir View